These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34172594)

  • 1. Importance of guidelines and networking for the management of rare gynecological cancers.
    Lainé A; Hanvic B; Ray-Coquard I
    Curr Opin Oncol; 2021 Sep; 33(5):442-446. PubMed ID: 34172594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France].
    Ray-Coquard I; Pautier P; Pujade-Lauraine E; Méeus P; Morice P; Treilleux I; Duvillard P; Alexandre J; Lhommé C; Selle F; Guastalla J
    Bull Cancer; 2010 Jan; 97(1):123-35. PubMed ID: 20007069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Networking for ovarian rare tumors: a significant breakthrough improving disease management.
    Chiannilkulchai N; Pautier P; Genestie C; Bats AS; Vacher-Lavenu MC; Devouassoux-Shisheboran M; Treilleux I; Floquet A; Croce S; Ferron G; Mery E; Pomel C; Penault-Llorca F; Lefeuvre-Plesse C; Henno S; Leblanc E; Lemaire AS; Averous G; Kurtz JE; Ray-Coquard I
    Ann Oncol; 2017 Jun; 28(6):1274-1279. PubMed ID: 28398524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging in gynecological disease (22): clinical and ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
    Moro F; Castellano LM; Franchi D; Epstein E; Fischerova D; Froyman W; Timmerman D; Zannoni GF; Scambia G; Valentin L; Testa AC; Mascilini F
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):987-994. PubMed ID: 33142349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of malignant ovarian germ cell tumors.
    Parkinson CA; Hatcher HM; Ajithkumar TV
    Obstet Gynecol Surv; 2011 Aug; 66(8):507-14. PubMed ID: 22018453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant mixed ovarian germ cell tumor with embryonal component.
    Moniaga NC; Randall LM
    J Pediatr Adolesc Gynecol; 2011 Feb; 24(1):e1-3. PubMed ID: 20869284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
    Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility management for malignant ovarian germ cell tumors patients.
    Di Tucci C; Casorelli A; Morrocchi E; Palaia I; Muzii L; Panici PB
    Crit Rev Oncol Hematol; 2017 Dec; 120():34-42. PubMed ID: 29198336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.
    Brown J; Friedlander M; Backes FJ; Harter P; O'Connor DM; de la Motte Rouge T; Lorusso D; Maenpaa J; Kim JW; Tenney ME; Seckl MJ
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S48-54. PubMed ID: 25341580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
    Rousset-Jablonski C; Selle F; Adda-Herzog E; Planchamp F; Selleret L; Pomel C; Chabbert-Buffet N; Daraï E; Pautier P; Trémollières F; Guyon F; Rouzier R; Laurence V; Chopin N; Faure-Conter C; Bentivegna E; Vacher-Lavenu MC; Lhomme C; Floquet A; Treilleux I; Lecuru F; Gouy S; Kalbacher E; Genestie C; de la Motte Rouge T; Ferron G; Devouassoux-Shisheboran M; Kurtz JE; Namer M; Joly F; Pujade-Lauraine E; Grynberg M; Querleu D; Morice P; Gompel A; Ray-Coquard I
    Bull Cancer; 2018 Mar; 105(3):299-314. PubMed ID: 29397916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers.
    Sessa C; Schneider DT; Planchamp F; Baust K; Braicu EI; Concin N; Godzinski J; McCluggage WG; Orbach D; Pautier P; Peccatori FA; Morice P; Calaminus G
    Lancet Oncol; 2020 Jul; 21(7):e360-e368. PubMed ID: 32615119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
    Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
    Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in ovarian germ cell tumors: A systematic review.
    Simone CG; Markham MJ; Dizon DS
    Gynecol Oncol; 2016 Jun; 141(3):602-607. PubMed ID: 26873864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.
    Abdul Razak AR; Li L; Bryant A; Diaz-Padilla I
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007584. PubMed ID: 21412906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary management of ovarian germ cell tumors and remaining controversies.
    Veneris JT; Mahajan P; Frazier AL
    Gynecol Oncol; 2020 Aug; 158(2):467-475. PubMed ID: 32507650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian stromal and germ cell tumors.
    Koulouris CR; Penson RT
    Semin Oncol; 2009 Apr; 36(2):126-36. PubMed ID: 19332247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
    Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
    Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.